首页 | 本学科首页   官方微博 | 高级检索  
     


Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A
Authors:R. Fossmark  Ø. Sørdal  C. S. Jianu  G. Qvigstad  I. S. Nordrum  M. Boyce  H. L. Waldum
Affiliation:1. Department of Gastroenterology and Hepatology, St. Olavs Hospital, , Trondheim, Norway;2. Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, , Trondheim, Norway;3. Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, NTNU, Medisinsk teknisk forskningssenter, , Trondheim, Norway;4. Department of Pathology and Medical Genetics, St. Olav's Hospital, Erling Skjalgssonsgate 1, , Trondheim, Norway;5. Hammersmith Medicines Research, , London, UK
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号